DLB Relative Valuation
DLB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, DLB is overvalued; if below, it's undervalued.
Historical Valuation
Dolby Laboratories Inc (DLB) is now in the Undervalued zone, suggesting that its current forward PE ratio of 19.10 is considered Undervalued compared with the five-year average of 22.76. The fair price of Dolby Laboratories Inc (DLB) is between 80.86 to 101.09 according to relative valuation methord. Compared to the current price of 74.74 USD , Dolby Laboratories Inc is Undervalued By 7.57%.
Relative Value
Fair Zone
80.86-101.09
Current Price：74.74
7.57%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
2.82
P/B
Median3y
3.16
Median5y
3.26
5.38
FCF Yield
Median3y
4.24
Median5y
4.13
Competitors Valuation Multiple
The average P/S ratio for DLB's competitors is 4.02, providing a benchmark for relative valuation. Dolby Laboratories Inc Corp (DLB) exhibits a P/S ratio of 5.30, which is 31.90% above the industry average. Given its robust revenue growth of 1.38%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is Dolby Laboratories Inc (DLB) currently overvalued or undervalued?
What is Dolby Laboratories Inc (DLB) fair value?
How does DLB's valuation metrics compare to the industry average?
What is the current P/B ratio for Dolby Laboratories Inc (DLB) as of Jul 08 2025?
What is the current FCF Yield for Dolby Laboratories Inc (DLB) as of Jul 08 2025?
What is the current Forward P/E ratio for Dolby Laboratories Inc (DLB) as of Jul 08 2025?